| Literature DB >> 26240654 |
Anastasios A Theodorou1, Vassilis Gerodimos2, Konstantina Karatrantou2, Vassilis Paschalis1, Konstantina Chanou2, Athanasios Z Jamurtas2, Michalis G Nikolaidis3.
Abstract
Whole-body vibration (WBV) exercise is an alternative, popular and easy exercise that can be followed by general public. Therefore, the aim of the present study was to investigate the influence of acute and chronic WBV exercise on health-related parameters. Twenty-eight women were allocated into a control group (n=11, mean ±SEM: age, 43.5 ±1.5 yr; body mass, 66.1 ±3.1 kg; height, 160.6 ±1.5 cm) and a vibration group (n=17, mean ±SEM: age, 44.0 ±1.0 yr; body mass, 67.1 ±2.2 kg; height, 162.5 ±1.5 cm). After baseline assessments, participants of the experimental group performed WBV training 3 times/week for 8 weeks. Before and after the chronic WBV exercise, the participants of the vibration group performed one session of acute WBV exercise. Blood chemistry measurements (hematology, creatine kinase, lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase, C-reactive protein, glucose, insulin, triacylglycerols, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein A1, apolipoprotein B and lipoprotein, thiobarbituric-acid reactive substances, protein carbonyls, total antioxidant capacity, uric acid, albumin and bilirubin) were assessed pre-exercise and post-exercise at the first and eighth week of WBV exercise in both control and vibration groups. The results failed to support any effect of both acute and chronic WBV exercise on biochemical health-related parameters. However, it seems that WBV exercise is a safe way of training without a negative impact on muscle and liver functionality.Entities:
Keywords: exercise; lipid profile; muscle damage; redox status; training; vibration
Year: 2015 PMID: 26240654 PMCID: PMC4519201 DOI: 10.1515/hukin-2015-0039
Source DB: PubMed Journal: J Hum Kinet ISSN: 1640-5544 Impact factor: 2.193
Hematologic variables in the control and vibration group pre and post exercise (mean ±SEM)
| Control (week 1) | Vibration (week 1) | Control (week 8) | Vibration (week 8) | |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| pre | post | pre | post | pre | post | pre | post | |
| Hct (%) | 38.2 ± 0.8 | 38.2 ± 0.8 | 38.6 ± 0.7 | 39.2 ± 0.7 | 38.0 ± 0.8 | 38.2 ± 0.8 | 38.0 ± 0.8 | 38.4 ± 0.7 |
| Hb (g·dL−1) | 12.5 ± 0.3 | 12.5 ± 0.3 | 12.5 ± 0.3 | 12.9 ± 0.3 | 12.3 ± 0.2 | 12.6 ± 0.3 | 12.4 ± 0.3 | 12.6 ± 0.3 |
| RBC (1012·L−1) | 4.6 ± 0.1 | 4.6 ± 0.1 | 4.8 ± 0.1 | 4.9 ± 0.1 | 4.6 ± 0.1 | 4.6 ± 0.1 | 4.8 ± 0.1 | 4.9 ± 0.1 |
| MCV (fL) | 84.1 ± 2.1 | 84.1 ± 2.1 | 80.9 ± 2.8 | 80.9 ± 2.8 | 83.5 ± 1.9 | 83.3 ± 1.9 | 80.6 ± 2.9 | 80.4 ± 2.9 |
| MCH (pg·cell−1) | 27.5 ± 0.8 | 27.4 ± 0.8 | 26.3 ± 1.1 | 26.4 ± 1.1 | 27.0 ± 0.8 | 27.0 ± 0.7 | 26.6 ± 1.1 | 26.4 ± 1.1 |
| MCHC (g·dL−1) | 32.7 ± 0.1 | 32.6 ± 0.2 | 32.4 ± 0.2 | 32.5 ± 0.3 | 32.7 ± 0.1 | 32.6 ± 0.2 | 32.8 ± 0.3 | 32.7 ± 0.3 |
| RDW(%) | 14.2 ± 0.6 | 14.0 ± 0.5 | 14.5 ± 0.5 | 14.5 ± 0.5 | 14.2 ± 0.5 | 13.9 ± 0.5 | 14.6 ± 0.6 | 14.6 ± 0.5 |
| WBC (109·L−1) | 6.5 ± 0.7 | 6.5 ± 0.7 | 7.1 ± 0.4 | 7.5 ± 0.4 | 6.4 ± 0.5 | 6.5 ± 0.5 | 7.6 ± 0.4 | 7.7 ± 0.4 |
| Neu (%) | 45.8 ± 2.6 | 47.0 ± 2.8 | 54.1 ± 1.8 | 55.2 ± 1.8 | 52.5 ± 1.5 | 51.9 ± 1.4 | 51.8 ± 1.7 | 52.2 ± 1.6 |
| Lymph (%) | 38.4 ± 1.5 | 39.2 ± 1.7 | 35.0 ± 1.9 | 34.1 ± 1.8 | 36.2 ± 1.6 | 37.6 ± 1.5 | 37.2 ± 1.7 | 36.8 ± 1.7 |
| Mono (%) | 8.2 ± 0.4 | 7.9 ± 0.3 | 7.9 ± 0.4 | 7.6 ± 0.3 | 8.5 ± 0.4 | 8.0 ± 0.4 | 8.1 ± 0.5 | 7.6 ± 0.5 |
| EO (%) | 2.0 ± 0.2 | 2.1 ± 0.2 | 2.5 ± 0.3 | 2.5 ± 0.3 | 2.3 ± 0.3 | 2.0 ± 0.2 | 2.4 ± 0.3 | 2.3 ± 0.3 |
| Baso (%) | 0.6 ± 0.1 | 0.5 ± 0.1 | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.5 ± 0.1 | 0.5 ± 0.1 | 0.6 ± 0.1 | 0.6 ± 0.1 |
| Plt (109·L−1) | 260 ± 10 | 259 ± 10 | 297 ± 18 | 213 ± 19 | 267 ± 12 | 268 ± 14 | 283 ± 18 | 292 ± 18 |
| MPV (fL) | 9.7 ± 0.2 | 9.6 ± 0.2 | 8.8 ± 0.2 | 9.1 ± 0.2 | 9.5 ± 0.3 | 9.6 ± 0.3 | 9.0 ± 0.2 | 9.0 ± 0.2 |
EO, Eosinophils; Hb, hemoglobin; Hct, hematocrit; Lymph, lymphocytes; MCH, mean cell hemoglobin; MCHC, mean cell hemoglobin concentration; MCV, mean cell volume; Mono, Monocytes; MPV, Mean platelet volume; Neu, neutrophils; Plt, platelets; RBC, red blood cells; RDW, red blood cell distribution width; WBC, white blood cells.
Muscle and liver and inflammation variables in the control and vibration group pre and post exercise (mean ±SEM)
| Control (week 1) | Vibration (week 1) | Control (week 8) | Vibration (week 8) | |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| pre | post | pre | post | pre | post | pre | post | |
| CK (U/L) | 153 ± 22 | 159 ± 21 | 153± 29 | 141 ± 27 | 123 ± 9 | 123 ± 12 | 103 ± 11 | 110 ± 13 |
| LDH (U/L) | 164± 10 | 163 ± 11 | 157 ± 11 | 152 ± 11 | 159 ± 10 | 154 ± 8 | 143 ± 8 | 145 ± 8 |
| AST (U/L) | 23.3 ± 2.6 | 23.3 ± 2.3 | 21.8 ± 1.7 | 21.3 ± 1.9 | 24.3 ± 2.6 | 24.1 ± 2.4 | 23.7 ± 1.2 | 23.1 ± 1.1 |
| ALT (U/L) | 25.4 ± 2.2 | 25.1 ± 2.1 | 24.3 ± 1.6 | 23.8 ± 1.3 | 24.0 ± 1.9 | 23.8 ± 1.6 | 25.2 ± 1.3 | 24.4 ± 1.6 |
| CRP (mg/L) | 0.22 ± 0.10 | 0.24 ± 0.11 | 0.16 ± 0.06 | 0.17 ± 0.05 | 0.20 ± 0.06 | 0.18 ± 0.06 | 0.11 ± 0.02 | 0.12 ± 0.02 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatine kinase; CRP, C-reactive protein; LDH, lactate dehydrogenase.
Figure 1Blood insulin resistance indices (glucose, insulin, HOMA) at pre-exercise and post-exercise in the first and eighth week of WBV exercise in the control (closed bars) and the vibration group (open bars).
*Significantly different from the pre-exercise value in the same group (P < 0.05)
Figure 2Blood lipid profile (TC, TG, HDLC, LDLC, TC/HDLC) at pre-exercise and post-exercise in the first and eighth week of WBV exercise in the control (closed bars) and the vibration group (open bars)
Redox status in the control and vibration group pre and post exercise (mean ±SEM)
| Control (week 1) | Vibration (week 1) | Control (week 8) | Vibration (week 8) | |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
| |||||
| pre | post | pre | post | pre | post | pre | post | |
| TBARS (μM) | 10.2 ± 0.7 | 10.8 ± 0.8 | 11.3± 0.7 | 11.5 ± 0.6 | 10.7 ± 0.6 | 10.9 ± 0.5 | 11.9 ± 0.5 | 12.4 ± 0.6 |
| Carbonyls (nmol/mg pr.) | 0.40 ± 0.04 | 0.42 ± 0.04 | 0.43 ± 0.03 | 0.39 ± 0.03 | 0.48 ± 0.04 | 0.46 ± 0.04 | 0.49 ± 0.04 | 0.42 ± 0.02 |
| TAC (mM DPPH) | 0.42 ± 0.03 | 0.39 ± 0.04 | 0.47 ± 0.04 | 0.44 ± 0.02 | 0.40 ± 0.05 | 0.48 ± 0.04 | 0.48 ± 0.03 | 0.53 ± 0.04 |
| Albumin (g/L) | 44.9 ± 0.6 | 45.5 ± 0.6 | 46.2± 0.5 | 46.0 ± 0.6 | 45.4 ± 0.7 | 45.0 ± 1.1 | 44.2 ± 0.5 | 44.8 ± 0.6 |
| Billirubin (μM) | 9.8 ± 0.5 | 9.9 ± 0.8 | 12.5± 1.5 | 11.9 ± 1.4 | 10.3 ± 0.8 | 9.8 ± 0.9 | 10.9 ± 1.2 | 11.4 ± 1.2 |
| Uric Acid (μM) | 0.38 ± 0.05 | 0.34 ± 0.05 | 0.34 ± 0.03 | 0.29 ± 0.04 | 0.38 ± 0.04 | 0.37 ± 0.04 | 0.35 ± 0.03 | 0.36 ± 0.04 |
TBARS, thiobarbituric-acid reactive substances; TAC, total antioxidant capacity